All stock lists
Lemaitre Vascular Inc (NASDAQ:LMAT)
US · Delayed Price · Currency is USD
Healthcare · Medical - Instruments & Supplies
$73.61-$1.25 (-1.67%)
Market cap
$1.68B
Insider Score
Health Score
Analyst consensus
Listed since
Oct 19, 2006
Website
LMAT analyst forecast
LMAT analyst consensus
Moderate Buy2 ratings
Buy 1 Hold 1 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
LMAT 12-month price target
$110.50+50.1% upsideaverage of 2 firms
$135.00High
$86.00Low
Best analysts covering LMAT
- Citizens100%success rate · +18.9% avg return · 1 call
- Barrington Research50%success rate · +5.6% avg return · 10 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
LMAT analyst ratings
Filters
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Citizens | Market Outperform | — | — | Reiterated | 2026-11-05 |
| Wells Fargo | Equal Weight | $86.00 | -2.2% | Reiterated | 2026-11-05 | |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2026-08-05 |
| — | Barrington Research | Outperform | — | — | Reiterated | 2026-06-03 |
| Lake Street | — | $135.00 | +28.1% | Price target | 2026-05-06 | |
| — | Roth Capital | Buy | — | — | Reiterated | 2026-02-26 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
